transparent gif
ImmuneSupport.com Home  
Medication tolerance and augmentation in restless legs syndrome:
The need for drug class rotation – Source: Journal of General Internal Medicine, Dec 2006
Fibromyalgia & Chronic Fatigue Syndrome Home Page Fibromyalgia & Chronic Fatigue Syndrome Library Fibromyalgia & Chronic Fatigue Syndrome Treatment and Research Email bulletins Fibromyalgia & Chronic Fatigue Syndrome Products Fibromyalgia & Chronic Fatigue Syndrome Community Area Fibromyalgia & Chronic Fatigue Syndrome About Us transparent gif transparent gif
transparent gif
Health Watch Newsletter background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
Home
Fibromyalgia Resources

Chronic Fatigue Syndrome Resources

E-mail Bulletin
Store
Community
About Us

Your Support Funds Research & Advocacy

Medication tolerance and augmentation in restless legs syndrome: The need for drug class rotation – Source: Journal of General Internal Medicine, Dec 2006


by R Kurlan, et al.
ImmuneSupport.com


12-01-2007

Advertisement
Restless legs syndrome (RLS) is a common condition characterized by an unpleasant urge to move the legs that usually occurs at night and may interfere with sleep. The medications used most commonly to treat RLS include dopaminergic drugs (levodopa, dopamine agonists), benzodiazepines, and narcotic analgesics.

We report the cases of 2 patients with RLS who illustrate the problems of tolerance (declining response over time) and augmentation (a worsening of symptoms due to ongoing treatment) that can complicate the pharmacotherapy of RLS.

We discuss the optimal management of RLS and propose strategies to overcome tolerance and augmentation such as a rotational approach among agents from different classes.

Source: Journal of General Internal Medicine. 2006 Dec;21(12):1338. PMID: 18049846, by Kurlan R, Richard IH, Deeley C. Movement Disorders Unit, Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA. [E-mail: Irene_Richard@urmc.rochester.edu ]

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
A Randomized, Double-blind, Placebo-Controlled, Phase III Trial of Pregabalin in the Treatment of Patients with Fibromyalgia – Source: Journal of Rheumatology, Feb 15, 2008
Rating of 2.3

Every purchase funds research, donations and the community resources provided within our website.

Organic & pure - 100% acacia
RenewLife Clear Fiber

Buffered for easy absorption
Pro-C Complex™ 500mg

Our new proprietary energy NADH
Energy NADH™ 10 mg

Getting your daily supplements has never been easier!
Daily Health ProPack™

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's ImmuneSupport.com- The World's Largest Fibromyalgia & Chronic Fatigue Syndrome Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee